Results     25-Apr-23
Announcements
Meghmani Finechem consolidated net profit declines 22.57% in the March 2023 quarter
Sales rise 12.71% to Rs 562.18 crore
Net profit of Meghmani Finechem declined 22.57% to Rs 76.73 crore in the quarter ended March 2023 as against Rs 99.09 crore during the previous quarter ended March 2022. Sales rose 12.71% to Rs 562.18 crore in the quarter ended March 2023 as against Rs 498.80 crore during the previous quarter ended March 2022.

For the full year,net profit rose 39.76% to Rs 353.29 crore in the year ended March 2023 as against Rs 252.79 crore during the previous year ended March 2022. Sales rose 41.10% to Rs 2188.40 crore in the year ended March 2023 as against Rs 1550.94 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales562.18498.80 13 2188.401550.94 41
OPM %27.5135.11 -31.4832.85 -
PBDT140.20165.26 -15 631.41469.33 35
PBT110.07144.20 -24 522.46383.42 36
NP76.7399.09 -23 353.29252.79 40

Previous News
  Meghmani Finechem consolidated net profit rises 191.64% in the June 2022 quarter
 ( Results - Announcements 21-Jul-22   16:34 )
  Epigral plans to add CPVC Compound capacity at Dahej
 ( Corporate News - 31-Aug-23   10:57 )
  Epigral forays into CPVC compounding segments with 35,000 TPA capacity plant
 ( Hot Pursuit - 31-Aug-23   12:27 )
  Meghmani Finechem awarded Responsible Care Certification by ICC
 ( Corporate News - 16-Mar-21   10:14 )
  Epigral signs agreement to source 19.80 MW wind solar hybrid power
 ( Corporate News - 04-Jun-25   11:09 )
  Meghmani Finechem expands caustic soda plant and upgrade captive power plant capacity
 ( Corporate News - 03-Nov-20   11:46 )
  Meghmani Finechem starts commercial production at new Hydrogen Peroxide plant
 ( Corporate News - 06-Aug-20   12:20 )
  Epigral consolidated net profit declines 58.50% in the September 2023 quarter
 ( Results - Announcements 06-Nov-23   17:40 )
  Epigral to hold board meeting
 ( Corporate News - 09-Apr-24   17:39 )
  Epigral
 ( Analyst Meet / AGM - Conference Call 06-May-25   08:19 )
  Epigral consolidated net profit declines 37.00% in the September 2025 quarter
 ( Results - Announcements 10-Nov-25   16:17 )
Other Stories
  Amrutanjan Health Care standalone net profit rises 18.31% in the September 2025 quarter
  10-Nov-25   18:05
  Oriental Aromatics standalone net profit declines 58.68% in the September 2025 quarter
  10-Nov-25   18:05
  EIH Associated Hotels standalone net profit rises 33.17% in the September 2025 quarter
  10-Nov-25   18:05
  Premier Polyfilm standalone net profit rises 1.91% in the September 2025 quarter
  10-Nov-25   18:05
  Ajcon Global Services standalone net profit declines 66.67% in the September 2025 quarter
  10-Nov-25   18:05
  Market Creators reports standalone net loss of Rs 0.24 crore in the September 2025 quarter
  10-Nov-25   18:05
  Sybly Industries reports standalone net loss of Rs 0.02 crore in the September 2025 quarter
  10-Nov-25   18:05
  Capital Finvest standalone net profit rises 16.67% in the September 2025 quarter
  10-Nov-25   18:05
  Rolex Rings standalone net profit declines 9.99% in the September 2025 quarter
  10-Nov-25   18:05
  Bajaj Consumer Care standalone net profit rises 29.73% in the September 2025 quarter
  10-Nov-25   18:05
Back Top